CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 10 No. 8
 

Dietary Changes May Help Prevent Skin Cancer, Expert Says

August 1, 2001

NEW YORK—A variety of simple dietary interventions could prove effective in inhibiting carcinogenesis and reducing the incidence of skin cancers, said James M. Spencer, MD, associate professor of dermatology, Mount Sinai School of Medicine, New York.

"Chemoprevention is a big research area, not just for skin cancer, and I think in the next few years, we’ll see many promising new candidates emerge," Dr. Spencer said at an American Academy of Dermatology (AAD) press conference.

In the setting of skin cancer, chemoprevention has already been demonstrated for vitamin A in relation to squamous cell carcinomas in moderate-risk populations, while vitamin A derivatives have proven effective for certain high-risk populations, Dr. Spencer said. However, he noted, long-term use would be limited by skeletal toxicity and other potential side effects. Other promising but less-toxic dietary approaches are under study now.

Research dating back to 1939 suggests that animals fed high-fat diets may be more susceptible to skin cancers, he said. More recently, a study found a relatively protective effect against UV-induced squamous cell carcinoma among mice fed a constant percentage of unsaturated fats vs mice fed saturated fats.

In one human study, patients with a history of nonmelanoma skin cancer went on a low-fat diet (20% of total calories) and were compared to a control group (38% of calories). At 2 years, there was a significant reduction in new skin cancers in the low-fat group, "although it is hard to get your fat content down to 20%," Dr. Spencer observed.

Vegetables, Grain, and Green Tea

Nutrients or non-nutrients (ie, trace elements such as selenium(Drug information on selenium)) in the diet may alter susceptibility to UV-induced skin cancers, he said. Research has shown that mice fed a crude diet of vegetables and grain have a lower liver cancer incidence than mice fed a semipurified diet.

Epigallocatechin-3-gallate (EGCG), a polyphenolic antioxidant found in green tea, has been of interest to researchers and health-food store customers. In mice, EGCG given topically or orally inhibits UV-induced skin cancer, he said.

Diets rich in soybeans have been associated with a lower incidence of breast, prostate, liver, and other cancers, he commented. In animal studies, high-soybean diets inhibited skin and other tumors induced by radiation or carcinogen.

Isoflavones have emerged as the leading potential protective candidate in soybeans. Genistein, the most potent of these phytochemicals, was shown in a Mount Sinai study of nude mice to be potentially effective for prevention of UV-induced carcinogenesis and sunburn. "Genistein is not a sunscreen—it does not block ultraviolet light; rather, it works later in the carcinogenic process," he said.

While entrepreneurs tout the purported health benefits of green tea and soybeans, the findings related to UV-induced carcinogenesis "belong in the laboratory at this point," Dr. Spencer said. "It’s an exciting research area, but certainly not proven, and they’re not even sure, exactly, which component of green tea might have this effect." That said, Dr. Spencer commented that higher-risk patients would now be candidates for "trivial" interventions, such as addition of soybeans to the diet, based on research findings to date, particularly if the intervention is cheap and carries little to no risk of long-term side effects.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Key Differences between FQHCs and RHCs
Chastity Werner, RHIT, June 13, 2013
FQHCs and RHCs take up a unique niche among physician practices. And that affects compensation and billing.
Improving Care Coordination in Your Practice
Susanne Madden,  June 12, 2013
Practices are feverishly working to control the rising costs of healthcare - effective care coordination can help.
Refunding Overpayments: Two Options for Medical Practices
Ericka L. Adler,  June 12, 2013
Medicare and Medicaid providers must return overpayments once identified. Here are two different refund approaches for practices to consider when necessary.
Four Easy Ways to Boost Patient Time of Service Collections
Aubrey Westgate,  June 12, 2013
Simple ways your medical practice staff can increase the likelihood patients will pay when presenting for appointments.
iPad Alternatives for Mobile Physicians
Marisa Torrieri, June 11, 2013
As more physicians are seeing the merits of media tablets, the market is expanding, too.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Papillary Thyroid Carcinoma
  • Robotic-Assisted Radical Prostatectomy: Who Is Benefiting?
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • A 48-Year-Old Woman With Irregular Vaginal Bleeding
  • Cannabis Linked to Decreased Bladder Cancer Risk
  • Breast Cancer Screening, Risk, and Options for High-Risk Women
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Rising PSA Level in a 46-Year-Old Man
  • ASCO: Long-Term Tamoxifen Benefit for Breast Cancer Confirmed
  • ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
  • Preventing Burnout in Oncology
  • ASCO: Yoga Reduces Insomnia in Breast Cancer Patients Treated With Hormone Therapy
  • Physical Activity Across the Cancer Continuum
  • Exercise After Cancer Diagnosis: Time to Get Moving
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy